Colgate-Palmolive Q3 earnings boosted after it raises prices again

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Singapore News News

Singapore Singapore Latest News,Singapore Singapore Headlines

Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

Consumer goods giant Colgate-Palmolive Co. CL, -0.45% posted better-than-expected third-quarter earnings early Friday, as it again raised prices by 9.5% globally. The company posted net income of $708 million, or 86 cents a share, for the quarter, up from $618 million, or 74 cents a share, in the year-earlier period. Adjusted per-share earnings also came to 86 cents, ahead of the 80 cent FactSet consensus. Sales rose to $4.915 billion from $4.455 billion a year ago, ahead of the $4.

The company said its base business gross profit margin rose 140 basis points to 58.6%, and was up 190 bps, excluding a negative 50 bps impact from private label sales stemming from the previously disclosed acquisitions of its pet food business. The company said it now expects full-year sales to grow 6% to 8%, compared with prior guidance of 5% to 8%. It expects adjusted EPS growth in the high-single digits, up from prior guidance of the high end of mid-single digits.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Singapore Singapore Latest News, Singapore Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Inflation report, energy earnings, Colgate-Palmolive: 3 things to watchInflation report, energy earnings, Colgate-Palmolive: 3 things to watch
Source: Investingcom - 🏆 450. / 53 Read more »

Boston Beer’s stock falls 6% after profit miss as company lowers guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »

Boston Scientific posts better-than-expected Q3 earningsCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »

Kenvue’s stock slides premarket as company reports slow start to flu and cold seasonCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »